Date | Insider | Price | Amount |
---|---|---|---|
9-20-2017 Insider Buy |
John Craig Thompson President & CEO |
$1.32 CAGR » |
$11,286.00 8,550 shares |
9-7-2017 Insider Buy |
John Craig Thompson President & CEO |
$1.43 CAGR » |
$14,892.80 10,400 shares |
9-7-2017 Insider Buy |
Paul F. Truex |
$1.34 CAGR » |
$6,700.00 5,000 shares |
6-24-2013 Insider Buy |
David E. Thompson |
$0.53 CAGR » |
$53,000.00 100,000 shares |
5-31-2013 Insider Buy |
Bogdan Dziurzynski |
$0.59 CAGR » |
$5,900.00 10,000 shares |
1-30-2013 Insider Buy |
ORBIMED ADVISORS LLC Director |
$0.66 CAGR » |
$3,762,000.00 5,700,000 shares |
6-29-2012 Insider Buy |
Christopher S. Henney Director |
$0.75 CAGR » |
$149,860.00 200,000 shares |
Also See: Institutional Holders of ANTH
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 09/21/2017 | |
End date: | 09/27/2021 | |
Start price/share: | $1.35 | |
End price/share: | $0.02 | |
Dividends collected/share: | $0.00 | |
Total return: | -98.52% | |
Average Annual Total Return: | -64.94% | |
Starting investment: | $10,000.00 | |
Ending investment: | $148.09 | |
Years: | 4.02 |
ANTH Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ANTH insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ANTH
Free ANTH Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |